We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Quest Diagnostics Sells OralDNA Labs to Access Genetics

By LabMedica International staff writers
Posted on 01 Jan 2013
Quest Diagnostics (Madison, NJ, USA), a provider of diagnostic information services, has sold substantially all of the assets of its OralDNA Labs salivary-diagnostics business to Access Genetics (Eden Prairie, MN, USA), a clinical laboratory with molecular diagnostics test development and information technology capabilities. More...
The terms of the transaction were not disclosed. This will allow Quest to refocus its resources on its core diagnostic information services business for physicians and hospitals.

Since 2008, Access Genetics has provided support and expertise for OralDNA-based testing services for dental professionals. As part of the transaction, OralDNA's testing services, now provided from a facility in Brentwood, TN (USA) will consolidate under Access Genetic's Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP)-certified laboratory in Eden Prairie, MN (USA).

Quest Diagnostics offers broad access to diagnostic information services through its network of laboratories and patient service centers, and provides consultation services through its medical and scientific staff.

Access Genetics provides web-based software, laboratory materials, and networked expertise to improve molecular diagnostics and patient care. The company offers comprehensive solutions to physicians including pathologists, and clinical laboratories for molecular (DNA-based) testing through a web-based Molecular Information System (TeleGene).

Related Links:
Quest Diagnostics
Access Genetics


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.